Assessment and management of coagulopathy in neurocritical care

다국어 초록 (Multilingual Abstract)

Coagulopathy may be defined as the loss of balance between hemostatic and fibrinolytic processes resulting in excessive bleeding, intravascular thrombosis or abnormalities in coagulation testing. It is frequently encountered across a wide range of conditions seen in the neurocritical care unit and can contribute to poor outcomes. Early recognition and appropriate management are key, with traumatic brain injury, acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage presenting unique challenges to the neurointensivist. We will discuss techniques to assess coagulopathies as well as treatment strategies for the brain injured patient.

참고문헌 (Reference)

1 Flibotte JJ, "Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage" 63 : 1059-1064, 2004

2 Dias JD, "Use of thromboelastography (TEG) for detection of new oral anticoagulants" 139 : 665-673, 2015

3 Choi PA, "Use of aspirin and P2Y12 response assays in detecting reversal of platelet inhibition with platelet transfusion in patients with traumatic brain injury on antiplatelet therapy" 80 : 98-104, 2017

4 de Oliveira Manoel AL, "Traumatic brain injury associated coagulopathy" 22 : 34-44, 2015

5 Kitchens CS, "To bleed or not to bleed? Is that the question for the PTT?" 3 : 2607-2611, 2005

6 Nakae R, "Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury" 33 : 688-695, 2016

7 Wallentin L, "Ticagrelor versus clopidogrel in patients with acute coronary syndromes" 361 : 1045-1057, 2009

8 Ramchand P, "Thromboelastography parameter predicts outcome after subarachnoid hemorrhage: an exploratory analysis" 96 : 215-221, 2016

9 Elliott A, "Thromboelastography in patients with acute ischemic stroke" 10 : 194-201, 2015

10 Ettinger MG, "Thromboelastographic studies in cerebral infarction" 5 : 350-354, 1974

11 Greinacher A, "Thrombocytopenia in the intensive care unit patient" 2010 : 135-143, 2010

12 Yao X, "Thrombelastography maximal clot strength could predict one-year functional outcome in patients with ischemic stroke" 38 : 182-190, 2014

13 McDonald MM, "Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke" 41 : 505-510, 2016

14 Kawano-Castillo J, "Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement" 45 : 683-688, 2014

15 Johansson PI, "Thrombelastography and tromboelastometry in assessing coagulopathy in trauma" 17 : 45-, 2009

16 Chan KH, "The significance of thrombocytopenia in the development of postoperative intracranial hematoma" 71 : 38-41, 1989

17 Frontera JA, "The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage" 26 : 48-57, 2017

18 Windeløv NA, "The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis" 22 : 416-419, 2011

19 Masotti L, "The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy" 6 : 228-240, 2011

20 Hirsh J, "The international normalized ratio. A guide to understanding and correcting its problems" 154 : 282-288, 1994

21 Flaherty ML, "The increasing incidence of anticoagulant-associated intracerebral hemorrhage" 68 : 116-121, 2007

22 Hess JR, "The coagulopathy of trauma: a review of mechanisms" 65 : 748-754, 2008

23 Walsh M, "Targeted thromboelastographic (TEG) blood component and pharmacologic hemostatic therapy in traumatic and acquired coagulopathy" 17 : 954-970, 2016

24 Sankarankutty A, "TEG® and ROTEM® in trauma: similar test but different results?" 7 (7): S3-, 2012

25 Tapia NM, "TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients" 74 : 378-385, 2013

26 Roderick P, "Simulation model of renal replacement therapy: predicting future demand in England" 19 : 692-701, 2004

27 Van Herzeele C, "Safety profile of desmopressin tablet for enuresis in a prospective study" 31 : 1306-1316, 2014

28 Creager MA, "Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events" 3 : 257-260, 1998

29 Naidech AM, "Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage" 40 : 2398-2401, 2009

30 Pabinger I, "Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial" 6 : 622-631, 2008

31 Wiviott SD, "Prasugrel versus clopidogrel in patients with acute coronary syndromes" 357 : 2001-2015, 2007

32 Baharoglu MI, "Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial" 387 : 2605-2613, 2016

33 Kang DW, "New ischemic lesions coexisting with acute intracerebral hemorrhage" 79 : 848-855, 2012

34 Stravitz RT, "Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography" 56 : 129-136, 2012

35 Vanderwerf JD, "Management of neurologic complications of coagulopathies" 141 : 743-764, 2017

36 Franke CL, "Intracerebral hematomas during anticoagulant treatment" 21 : 726-730, 1990

37 Veltkamp R, "Intracerebral bleeding in patients on antithrombotic agents" 39 : 963-971, 2013

38 Strauss R, "Incidence and implications of coagulopathy in medical intensive care patients" 5 (5): P105-, 2001

39 Schreiber MA, "Hypercoagulability is most prevalent early after injury and in female patients" 58 : 475-480, 2005

40 Hemphill JC 3rd, "Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association" 46 : 2032-2060, 2015

41 Levi M, "Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology" 145 : 24-33, 2009

42 Frontera JA, "Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine" 24 : 6-46, 2016

43 Furay E, "Goal-directed platelet transfusions correct platelet dysfunction and may improve survival in patients with severe traumatic brain injury" 85 : 881-887, 2018

44 Gonzalez E, "Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays" 263 : 1051-1059, 2016

45 Connolly SJ, "Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors" 380 : 1326-1335, 2019

46 Steiner T, "Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial" 15 : 566-573, 2016

47 Goldstein JN, "Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial" 385 : 2077-2087, 2015

48 Sarode R, "Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study" 128 : 1234-1243, 2013

49 Marlu R, "Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers" 108 : 217-224, 2012

50 Johansson PI, "Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study" 96 : 111-118, 2009

51 Jin L, "Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery" 128 : 644-647, 2015

52 Gordz S, "Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand’s disease" 32 : 83-87, 2005

53 Naidech AM, "Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage" 16 : 82-87, 2012

54 Mark M. McDonald, "Dual Antiplatelet Therapy Is Associated With Coagulopathy Detectable by Thrombelastography in Acute Stroke" SAGE Publications 35 (35): 68-73, 2017

55 Kim JH, "Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures" 94 : 1457-1461, 2015

56 Naidech AM, "Desmopressin improves platelet activity in acute intracerebral hemorrhage" 45 : 2451-2453, 2014

57 Wademan BH, "Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults" 18 : 360-370, 2014

58 Reiter RA, "Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin" 102 : 4594-4599, 2003

59 Kapapa T, "Desmopressin acetate in intracranial haemorrhage" 2014 : 298767-, 2014

60 Zeigler ZR, "Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia" 39 : 90-95, 1992

61 Calmer S, "Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro" 25 : 8-15, 2014

62 Mannucci PM, "Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia" 308 : 8-12, 1983

63 Pollack CV Jr, "Dabigatran reversal with idarucizumab" 377 : 1691-1692, 2017

64 Mannucci PM, "Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time" 67 : 1148-1153, 1986

65 Lauridsen SV, "Coagulation profile after spontaneous intracerebral hemorrhage: a cohort study" 27 : 2951-2961, 2018

66 Harhangi BS, "Coagulation disorders after traumatic brain injury" 150 : 165-175, 2008

67 Ettinger MG, "Coagulation abnormalities in subarachnoid hemorrhage" 1 : 139-142, 1970

68 Levi M, "Coagulation abnormalities in critically ill patients" 10 : 222-, 2006

69 ACTIVE Writing Group of the ACTIVE Investigators, "Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial" 367 : 1903-1912, 2006

70 Tcheng JE, "Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment" 139 (139): S38-S45, 2000

71 Larsen CC, "Blood coagulation and fibrinolysis after experimental subarachnoid hemorrhage" 152 : 1577-1581, 2010

72 Pavord S, "Bleeding and thrombotic complications of kidney disease" 25 : 271-278, 2011

73 Hunt BJ, "Bleeding and coagulopathies in critical care" 58 : 274-275, 2014

74 Khan NI, "Association between previous use of antiplatelet therapy and intracerebral hemorrhage outcomes" 48 : 1810-1817, 2017

75 Collyer TC, "Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping" 102 : 492-498, 2009

76 Lindblad C, "Assessment of platelet function in traumatic brain injury: a retrospective observational study in the neuro-critical care setting" 9 : 15-, 2018

77 Sibbing D, "Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment" 99 : 121-126, 2008

78 He J, "Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials" 280 : 1930-1935, 1998

79 Holcomb JB, "Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients" 256 : 476-486, 2012

80 Abdelmalik PA, "Acute traumatic coagulopathy accompanying isolated traumatic brain injury is associated with worse long-term functional and cognitive outcomes" 24 : 361-370, 2016